Scientific article
Open access

Prévention de l'AVC chez les patients avec une fibrillation auriculaire

Published inRevue médicale suisse, vol. 13, no. 560, p. 911-915
Publication date2017

Oral anticoagulation with vitamin K antagonists (VKA) was the cornerstone of stroke prevention in atrial fibrillation (AF). This review article presents the state of the art, with regard to the treatment options developed over the past few years, the new oral anticoagulants (NOAC). A search in PubMed for relevant published studies has been performed. Dabigatran and apixaban were superior to warfarin to reduce stroke risk or systemic embolism ; dabigatran, rivaroxaban and edoxaban were non-inferior. All NOAC are globally non-inferior to warfarin for stroke prevention in non-valvular AF and they have a superior safety profile, with a reduced intracranial bleeding risk. They are now the first choice for treatment.

Citation (ISO format)
SIRIMARCO, Gaia et al. Prévention de l’AVC chez les patients avec une fibrillation auriculaire. In: Revue médicale suisse, 2017, vol. 13, n° 560, p. 911–915.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation11/08/2017 3:05:00 PM
First validation11/08/2017 3:05:00 PM
Update time03/15/2023 7:40:21 AM
Status update03/15/2023 7:40:20 AM
Last indexation02/12/2024 12:48:17 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack